STOCK TITAN

Merit Medical Shareholders Elect Scott R. Ward to Board of Directors

(Neutral)
(Positive)
Tags
management

Merit Medical (NASDAQ: MMSI) announced that shareholders elected Scott R. Ward to its Board of Directors at the May 19, 2026 annual meeting. Ward will serve a three-year term and join the Board’s Governance and Sustainability and Finance and Operating Committees.

Ward brings over 40 years of healthcare and medical device leadership, including senior roles at Medtronic, CEO and Chairman of Cardiovascular Systems during its sale to Abbott, and founder of Raymond Holdings.

Loading...
Loading translation...

Positive

  • Shareholders elect Scott R. Ward to a three-year board term
  • Adds director with more than 40 years healthcare and device experience
  • Experience leading Cardiovascular Systems through expansion and sale to Abbott
  • Appointed to Governance and Sustainability and Finance and Operating Committees

Negative

  • None.

News Market Reaction – MMSI

+0.20%
+0.20% Session close to close

In the May 19 session, MMSI gained 0.20%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. Ward to the company’s Board of Directors at Merit’s annual meeting of shareholders.

Mr. Ward was elected to serve a three-year term.

“On behalf of the Board, we are pleased with Scott Ward’s election to Merit’s Board of Directors,” said F. Ann Millner, Merit’s Chair of the Board. “Scott’s extensive industry experience, strategic insight, and commitment to innovation will be tremendous assets as we continue advancing the company’s strategic priorities.”

“We are proud to welcome Scott Ward to Merit’s Board,” said Martha G. Aronson, Merit’s President and Chief Executive Officer. “Scott brings deep medical device experience and a proven leadership track record. As we continue building on our foundation and advancing our strategy, his perspective will be invaluable to our long-term growth.”

“I am honored to join the Merit Board of Directors,” Ward said. “I have great respect for Merit’s commitment to innovation and its focus on serving patients and healthcare providers around the world. I look forward to contributing my experience as the company continues to grow and expand its impact.”

Mr. Ward brings more than 40 years of experience in the healthcare and medical device industry, including nearly three decades at Medtronic, where he held senior leadership roles such as senior vice president and president of the cardiovascular, neurological, and diabetes businesses. He most recently served as CEO, President and Chairman of Cardiovascular Systems, Inc., leading the company through a period of expansion and its acquisition by Abbott.

Mr. Ward is also the founder of Raymond Holdings, a firm focused on venture capital, strategy, and advisory services for medical technology and life sciences companies, and has served on numerous public and private company boards. Merit’s Board of Directors has appointed Mr. Ward to serve on its Governance and Sustainability and Finance and Operating Committees.

ABOUT MERIT MEDICAL

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.

TRADEMARKS

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

CONTACTS
Media Inquiries
Sarah Comstock

Merit Medical
+1-801-432-2864 | sarah.comstock@merit.com

Investor Inquiries
Mike Piccinino, CFA, IRC

ICR Healthcare
+1-443-213-0509 | mike.piccinino@icrhealthcare.com


FAQ

What did Merit Medical (NASDAQ: MMSI) announce about its board on May 19, 2026?

Merit Medical announced that shareholders elected Scott R. Ward to its Board of Directors for a three-year term. According to Merit, Ward will also serve on the Governance and Sustainability and Finance and Operating Committees, strengthening board oversight and strategic guidance.

Who is Scott R. Ward, newly elected to the Merit Medical (MMSI) board?

Scott R. Ward is a healthcare executive with over 40 years of medical device experience. According to Merit, he previously held senior leadership roles at Medtronic, led Cardiovascular Systems as CEO and Chairman, and founded Raymond Holdings, a medical technology-focused advisory and venture firm.

What committees will Scott R. Ward join on the Merit Medical (MMSI) board?

Scott R. Ward will serve on Merit Medical’s Governance and Sustainability and Finance and Operating Committees. According to Merit, these assignments position him to influence board governance, sustainability priorities, and financial and operational oversight as the company advances its long-term strategic initiatives.

How much industry experience does Scott R. Ward bring to the Merit Medical (MMSI) board?

Scott R. Ward brings more than 40 years of experience in healthcare and medical devices. According to Merit, his background spans nearly three decades at Medtronic and leadership of Cardiovascular Systems, including guiding that company through expansion and its acquisition by Abbott.

Why does Merit Medical (MMSI) consider Scott R. Ward’s election important for its strategy?

Merit Medical views Scott R. Ward’s election as support for its strategic priorities and long-term growth. According to Merit, his deep medical device experience, strategic insight, and innovation focus are expected to help advance the company’s strategy and broaden its impact in global healthcare.

What previous leadership roles did Scott R. Ward hold before joining the Merit Medical (MMSI) board?

Before joining Merit’s board, Scott R. Ward held senior roles at Medtronic and led Cardiovascular Systems. According to Merit, he served as senior vice president at Medtronic and later as CEO, President, and Chairman of Cardiovascular Systems during a period of business expansion and sale to Abbott.